RxDoctor Payments Data

Christopher Ellis

Family · Plains, PANPI 1366026361

Payments from drug & device makers

$7,221in general payments, 2019–2025

Across 431 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • AstraZeneca$967
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$643
  • Amgen$636
  • Johnson & Johnson$615
  • Boehringer Ingelheim$531
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$7,15199%
  • Education$701%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,221 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban111$96,417
EntrestoSacubitril/Valsartan58$57,652
JardianceEmpagliflozin31$29,395
FarxigaDapagliflozin Propanediol29$20,727
BrilintaTicagrelor19$12,709
XareltoRivaroxaban14$11,578
ClopidogrelClopidogrel Bisulfate173$2,779
Metoprolol Succinate199$2,730
Atorvastatin Calcium220$2,150
Labetalol Hcl57$2,026
Potassium Chloride101$1,687
Carvedilol165$1,625
Ranolazine ErRanolazine39$1,521
Amiodarone Hcl79$1,471
Isosorbide Mononitrate ErIsosorbide Mononitrate77$1,439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$398$96,417111 claims
NovartisEntresto$1,071$57,65258 claims
AstraZenecaFarxiga, Brilinta$967$33,43648 claims
Boehringer IngelheimJardiance$531$29,39531 claims
Johnson & JohnsonXarelto$615$11,57814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.

Other family in Plains

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →